Clinical trials
Completed beta-Thalassemia trials in the United States
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
40 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2000 | 4 |
| 2003 | 3 |
| 2004 | 1 |
| 2006 | 1 |
| 2007 | 1 |
| 2008 | 5 |
| 2009 | 1 |
| 2010 | 1 |
| 2011 | 2 |
| 2012 | 2 |
| 2013 | 2 |
| 2014 | 2 |
| 2016 | 2 |
| 2017 | 1 |
| 2018 | 3 |
| 2019 | 2 |
| 2020 | 1 |
| 2022 | 1 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 40 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Celgene | 3 |
| National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) | 3 |
| Novartis Pharmaceuticals | 3 |
| Carelon Research | 2 |
| Genetix Biotherapeutics Inc. | 2 |
| Ann & Robert H Lurie Children's Hospital of Chicago | 1 |
| Boston Children's Hospital | 1 |
| Boston University | 1 |
| Columbia University | 1 |
| Dana-Farber Cancer Institute | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| beta-Thalassemia | 40 |
| Anemia, Sickle Cell | 16 |
| Thalassemia | 11 |
| Iron Overload | 10 |
| Hematologic Diseases | 8 |
| Genetic Diseases, Inborn | 6 |
| Anemia, Aplastic | 4 |
| Anemia, Diamond-Blackfan | 4 |
| Rare Diseases | 4 |
| Anemia | 3 |
Trials
Showing 1 to 25 of 40. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.